Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    pf- 04494700
Show Display Options
Rank Status Study
1 Completed A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: PF-04494700;   Drug: Placebo
2 Completed A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients
Condition: Alzheimer Disease
Interventions: Drug: PF-04494700 - Low Dose Arm;   Drug: PF-04494700 - High Dose Arm;   Drug: Placebo Comparator
3 Completed 6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: PF-04494700 (TTP488);   Other: Placebo

Indicates status has not been verified in more than two years